EMXC.DE vs. NOV.DE
EMXC.DE (Lyxor MSCI Emerging Markets Ex China UCITS ETF - Acc) is Emerging Markets Equities fund tracking the MSCI EM NR USD, while NOV.DE (Novo Nordisk A/S) is a stock. Over the past 5 years, EMXC.DE returned 13.45%/yr vs 20.26%/yr for NOV.DE. At a 0.16 correlation, their price movements are largely independent.
Performance
EMXC.DE vs. NOV.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EMXC.DE achieves a 39.32% return, which is significantly higher than NOV.DE's -10.35% return.
EMXC.DE
- 1D
- 3.50%
- 1M
- 6.96%
- YTD
- 39.32%
- 6M
- 44.08%
- 1Y
- 66.94%
- 3Y*
- 23.90%
- 5Y*
- 13.45%
- 10Y*
- —
NOV.DE
- 1D
- 0.21%
- 1M
- -0.63%
- YTD
- -10.35%
- 6M
- -8.05%
- 1Y
- -42.30%
- 3Y*
- 4.29%
- 5Y*
- 20.26%
- 10Y*
- 17.16%
EMXC.DE vs. NOV.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
EMXC.DE Lyxor MSCI Emerging Markets Ex China UCITS ETF - Acc | 39.32% | 19.92% | 9.13% | 14.31% | -13.59% | 17.56% | 2.25% | -4.50% |
NOV.DE Novo Nordisk A/S | -10.35% | -45.88% | -9.45% | 201.62% | 32.53% | 76.94% | 16.00% | 14.55% |
Correlation
The correlation between EMXC.DE and NOV.DE is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jun 20, 2019 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EMXC.DE vs. NOV.DE — Risk / Return Rank
EMXC.DE
NOV.DE
EMXC.DE vs. NOV.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lyxor MSCI Emerging Markets Ex China UCITS ETF - Acc (EMXC.DE) and Novo Nordisk A/S (NOV.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EMXC.DE | NOV.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.97 | ||
| Sortino ratioReturn per unit of downside risk | +5.08 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 0.85 | +0.71 |
| Calmar ratioReturn relative to maximum drawdown | 5.41 | -0.80 | +6.21 |
| Martin ratioReturn relative to average drawdown | 19.68 | -1.16 | +20.84 |
Loading charts...
Drawdowns
EMXC.DE vs. NOV.DE - Drawdown Comparison
The maximum EMXC.DE drawdown since its inception was -40.89%, smaller than the maximum NOV.DE drawdown of -76.24%. Use the drawdown chart below to compare losses from any high point for EMXC.DE and NOV.DE.
Loading charts...
Drawdown Indicators
| EMXC.DE | NOV.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.89% | -76.24% | +35.35% |
Max Drawdown (1Y)Largest decline over 1 year | -11.87% | -53.78% | +41.91% |
Max Drawdown (3Y)Largest decline over 3 years | -20.47% | -76.24% | +55.77% |
Max Drawdown (5Y)Largest decline over 5 years | -20.47% | -76.24% | +55.77% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.24% | — |
Current DrawdownCurrent decline from peak | -3.16% | -70.33% | +67.17% |
Average DrawdownAverage peak-to-trough decline | -7.75% | -11.57% | +3.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.27% | 35.53% | -32.26% |
Volatility
EMXC.DE vs. NOV.DE - Volatility Comparison
The current volatility for Lyxor MSCI Emerging Markets Ex China UCITS ETF - Acc (EMXC.DE) is 8.60%, while Novo Nordisk A/S (NOV.DE) has a volatility of 9.39%. This indicates that EMXC.DE experiences smaller price fluctuations and is considered to be less risky than NOV.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EMXC.DE | NOV.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.60% | 9.39% | -0.79% |
Volatility (6M)Calculated over the trailing 6-month period | 18.13% | 37.99% | -19.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.61% | 50.46% | -29.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.02% | 57.30% | -41.28% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.88% | 44.50% | -25.62% |
Dividends
EMXC.DE vs. NOV.DE - Dividend Comparison
EMXC.DE has not paid dividends to shareholders, while NOV.DE's dividend yield for the trailing twelve months is around 4.10%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EMXC.DE Lyxor MSCI Emerging Markets Ex China UCITS ETF - Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NOV.DE Novo Nordisk A/S | 4.10% | 3.54% | 1.59% | 1.02% | 2.36% | 2.54% | 3.97% | 4.18% | 5.34% | 4.55% | 7.38% | 2.50% |
Frequently Asked Questions
EMXC.DE and NOV.DE have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for EMXC.DE and NOV.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer